Combined PET/MRI: a new dimension in whole-body oncology imaging?

G Antoch, A Bockisch - European journal of nuclear medicine and …, 2009 - Springer
Introduction Hybrid imaging systems providing morphological and functional data in a single
session have been available for oncological imaging for some time. So far, computed …

Current concepts in the mediastinal lymph node staging of nonsmall cell lung cancer

H Kramer, HJM Groen - Annals of surgery, 2003 - journals.lww.com
Current Concepts in the Mediastinal Lymph Node Staging of No... : Annals of Surgery Current
Concepts in the Mediastinal Lymph Node Staging of Nonsmall Cell Lung Cancer : Annals of …

Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology

G Antoch, FM Vogt, LS Freudenberg, F Nazaradeh… - Jama, 2003 - jamanetwork.com
ContextDeciding on the appropriate therapy for patients with malignant diseases mandates
accurate tumor staging with whole-body coverage. Magnetic resonance imaging (MRI) and …

Accuracy of Whole-Body Dual-Modality Fluorine-18–2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography and Computed Tomography (FDG-PET/CT) for …

G Antoch, N Saoudi, H Kuehl, G Dahmen… - Journal of Clinical …, 2004 - ascopubs.org
Purpose To assess the accuracy of positron emission tomography/computed tomography
(PET/CT) when staging different malignant diseases. Patients and Methods This was a …

Lymph node dissection–understanding the immunological function of lymph nodes

M Buettner, U Bode - Clinical & Experimental Immunology, 2012 - academic.oup.com
Lymph nodes (LN) are one of the important sites in the body where immune responses to
pathogenic antigens are initiated. This immunological function induced by cells within the …

Neutrophil‑to‑lymphocyte and platelet‑to‑lymphocyte ratios may aid in identifying patients with non‑small cell lung cancer and predicting Tumor‑Node‑Metastasis …

F Xu, P Xu, W Cui, W Gong, Y Wei… - Oncology …, 2018 - spandidos-publications.com
The present study aimed to identify a high‑risk population with non‑small cell lung cancer
(NSCLC) and to predict TNM stages using the neutrophil‑to‑lymphocyte ratio (NLR) and the …

Clinical applications of positron emission tomography-computed tomography in oncology.

R Kumar, D Halanaik, A Malhotra - Indian journal of cancer, 2010 - search.ebscohost.com
Positron emission computed tomography (PET) is a functional diagnostic imaging technique,
which can accurately measure in vivo distribution of a variety of radiopharmaceuticals. The …

Diagnostic efficacy of PET and PET/CT for recurrent lung cancer: a meta-analysis

YQ He, HL Gong, YF Deng, WM Li - Acta Radiologica, 2014 - journals.sagepub.com
Background Lung cancer is one of the most common malignant tumors in the world, and is
the leading cause of cancer-related mortality. Although there are no conclusive data to …

[PDF][PDF] Screening of brain metastasis with limited magnetic resonance imaging (MRI): clinical implications of using limited brain MRI during initial staging for non-small …

SY Kim, JS Kim, HS Park, MJ Cho… - Journal of Korean …, 2005 - synapse.koreamed.org
The purpose of this prospective study was to determine whether using magnetic resonance
imaging (MRI) for early screening for brain metastases (BM) can improve quality of life …

Fast T1-and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma

M Both, J Schultze, M Reuter, B Bewig… - European journal of …, 2005 - Elsevier
PURPOSE:: A prospective study to evaluate the diagnostic potential and limitations of three
fast MRI sequences in patients with bronchial carcinoma based on the comparison with …